Doctors Recommend A New Drug For The Prevention Of HIV Infection

Doctors Recommend A New Drug For The Prevention Of HIV Infection.
Should common man in peril of contracting HIV because they have risky sex carry a pill to prevent infection, or will the medication encourage them to take even more sexual risks? After years of contest on this question, a new international study suggests the medication doesn't lead mortals to stop using condoms or have more sex with more people. The research isn't definitive, and it hasn't changed the thoughts of every expert rxlistbox com. But one of the study's co-authors said the findings support the drug's use as a means to prevent infection with HIV, the virus that causes AIDS.

And "People may have more partners or stop using condoms, but as well as we can tell, it's not because of taking the upper to prevent HIV infection ," said study co-author Dr Robert Grant, a major investigator with the Gladstone Institute of Virology and Immunology in San Francisco. The medication in beyond is called Truvada, which combines the drugs emtricitabine and tenofovir whosphil.com. It's normally utilized to treat people who are infected with HIV, but research - in vivid and bisexual men and in straight couples with one infected partner - have shown that it can lower the risk of infection in multitude who become exposed to the virus through sex.

However, it does not eliminate the risk of infection. The US Food and Drug Administration approved the cure for prevention purposes in 2012. Few people seem to be taking it for check purposes, however. Its manufacturer, Gilead, has disclosed that about 1700 people are taking the drug for that mind in the United States, Grant said. In the new study, researchers found that expected rates of HIV and syphilis infection decreased in almost 2500 men and transgender women when they took Truvada.

The inquiry participants, who all faced excessive risk of HIV infection, were recruited in Peru, Ecuador, South Africa, Brazil, Thailand and the United States. Some of the participants took Truvada while others took an out of work placebo. Those who believed they were taking Truvada "were just as permissible as everybody else," Grant said, suggesting that they weren't more likely to stop using condoms or be more promiscuous because they believed they had unexpectedly protection against HIV infection.

Grant said the design of the study allows scientists to better make out the choices that participants make. The study is limited, however, because the researchers recruited participants as an alternative of waiting for people to come to them. For that reason, it's impossible to know if living souls will seek out Truvada to take new levels of risk by, say, no longer using condoms. There are many skeptics, including the AIDS Healthcare Foundation, who fears that the opiate will simply aid people to make riskier decisions in regard to sex.

One of these skeptics is Arleen Leibowitz, a professor emeritus of segment policy at the Luskin School of Public Affairs at the University of California, Los Angeles. She said the deliberate over shows that many people failed to take Truvada as prescribed and often didn't lure enough to be protected from HIV. That raises the prospect that some people would take risks because they maintain they're protected when they actually aren't, she noted.

Leibowitz also said some of the statistics in the study are debatable because they don't include enough participants. And she said the participants may have lied about their sex lives to delight the people who interviewed them. "We'll learn a lot when its use becomes more general. But it's pitiable to do experiments on the general population".

For the moment, she said, the drug may be appropriate for some patients who need guard from HIV, but doctors should be cautious and make sure their patients take the medication. The learn is published in the Dec 18, 2013 online edition of the journal PLoS One oxyhives.herbalous.com. In other HIV/AIDS news, a unusual study - also published in PLoS One - reports that 20-year-old men infected with HIV in the United States and Canada can envisage to live almost as eat one's heart out as the general population and make it, typically, to their early 70s.